Oregovomab and non-platinum chemotherapy in PARP inhibitor-resistant ovarian, fallopian tube, or primary peritoneal cancer patients not candidates for platinum retreatment: A multicenter, two-cohort, single-arm phase 2 trial (OPERA/KGOG 3065/APGOT-OV6).

pegylated liposomal doxorubicin - Generic mfg.

paclitaxel - Generic mfg.

Avastin (bevacizumab) - Roche

OvaRex (oregovomab) - CanariaBio

JUNG-YUN LEE; Junsik Park; Chel Hun Choi; Hyun Woong Cho; Jae Hong No; Dae Gy Hong

Apr 27, 2023